Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
OLAM International's second-quarter earnings have trebled to S$94.7 million despite lower revenue and a net loss from changes in the valuation of biological assets.
The surge in profit attributable to shareholders was helped by a sharp drop in profit attributable to non-...